As BTS gears up for its highly anticipated comeback with the album ARIRANG on March 20, 2026, leader RM has opened up about ...

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight. By Dani Blum Weight-loss drugs like ...

LONDON, UNITED KINGDOM - OCTOBER 21: A photo illustration of a woman with an Ozempic (semaglutide) injection pen. (Photo by Peter Dazeley/Getty Images) High patient out-of-pocket costs and side ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Celebrities have been striving for health in 2025, with many dropping significant amounts of weight — in many cases with the help of GLP-1 medications like Ozempic. Below are four A-list stars who ...

California will end Medi-Cal coverage for popular weight-loss drugs like Wegovy starting Jan. 1, citing soaring pharmaceutical costs. Low-income residents losing coverage will be advised to rely on ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...